| Year | 2023 | 2022 |
|---|---|---|
| CF from Operating Activities | 2.16B | 2.63B |
| Net Income | 2.17B | 2.61B |
| Depreciation & Amortization | 732.35M | 625.4M |
| Deferred Income Taxes | 0 | 0 |
| Stock Based Compensation | 2.28M | 0 |
| Change in Working Capital | -1.65B | -172.1M |
| Accounts Receivable | -1.26B | -207.6M |
| Inventory | -396.6M | -1.27B |
| Accounts Payable | 433.5M | 1.3B |
| Other Working Capital | -433.49M | 70K |
| Other Non-Cash Items | 911.88M | -431M |
| CF from Investing Activities | 2.16B | 2.63B |
| Investments in Property, Plant & Equipment | -1.56B | -1.2B |
| Net Acquisitions | 0 | 0 |
| Investment Purchases | -194.04M | -391.23M |
| Sales/Maturities of Investments | 5.51M | 0 |
| Other Investing Activites | -401.07M | 9.73M |
| CF from Financing Activities | 97.24M | -1.63B |
| Debt Repayment | 499.93M | -1.24B |
| Common Stock Issued | 0 | 0 |
| Common Stock Repurchased | 0 | 0 |
| Dividends Paid | -181.25M | -181.25M |
| Other Financing Activites | -221.45M | -210.52M |
| Free Cash Flow | 175.7M | 1.43B |
| Operating Cash Flow | 2.16B | 2.63B |
| Capital Expenditures | -1.99B | -1.2B |
| Cash at Beginning of Period | 121.21M | 832.7M |
| Cash at End of Period | 236.35M | 250M |
| Net Change In Cash | 115.14M | -582.7M |
Aarti Pharmalabs Limited
AARTIPHARM.NS
NSE
679.4INR55 (-0.25%)
AARTIPHARM.NS Financial Statements
Retained Earning Schedule
| Year | 2023 | 2022 |
|---|---|---|
| Retained Earnings (Previous Year) | 8.89B | 7.17B |
| Net Income | 2.17B | 1.93B |
| Stock Repurchases | 0 | 0 |
| Dividend Paid | -181.25M | -181.25M |
| Retained Earnings | 10.86B | 8.89B |
| Other Distributions | 1.78B | 1.54B |
PPE Schedule
| Year | 2023 | 2022 |
|---|---|---|
| Gross PPE | 11.05B | 9.86B |
| Annual Depreciation | 732.35M | 625.43M |
| Capital Expenditure | -1.99B | -1.2B |
| Net PPE | 12.31B | 10.43B |
Intangible and Goodwill Schedule
| Year | 2023 | 2022 |
|---|---|---|
| Acquisitions and Adjustments | 6K | -6K |
| Goodwill (Previous Year) | 17.8M | 17.81M |
| Goodwill | 17.81M | 17.8M |